{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:39:15Z","timestamp":1794368355478,"version":"4.9.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["MIS F.4512.20"],"award-info":[{"award-number":["MIS F.4512.20"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.molmed.2021.12.006","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:10:46Z","timestamp":1642723846000},"page":"223-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":190,"title":["Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2040-768X","authenticated-orcid":false,"given":"Morgane M.","family":"Thibaut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3747-3234","authenticated-orcid":false,"given":"Laure B.","family":"Bindels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2021.12.006_bb0005","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2021.12.006_bb0010","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/apt.16602","article-title":"Review article: therapeutic aspects of bile acid signalling in the gut-liver axis","volume":"54","author":"Simbrunner","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2021.12.006_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/164_2019_236","article-title":"Bile acid-activated receptors: a review on FXR and other nuclear receptors","volume":"256","author":"Shin","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107867","article-title":"The pathophysiological function of non-gastrointestinal farnesoid X receptor","volume":"226","author":"Yan","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2021.12.006_bb0025","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.molimm.2006.04.021","article-title":"Nuclear receptors in human immune cells: expression and correlations","volume":"44","author":"Schote","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0030","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.12.006_bb0035","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.12.006_bb0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2021.12.006_bb0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmed.2021.10.005","article-title":"Linking liver metabolic and vascular disease via bile acid signaling","volume":"28","author":"Fiorucci","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2021.12.006_bb0055","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile acids activated receptors regulate innate immunity","volume":"9","author":"Fiorucci","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0060","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2021.12.006_bb0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2021.12.006_bb0070","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/hep.32028","article-title":"Mast cells regulate ductular reaction and intestinal inflammation in cholestasis through farnesoid X receptor signaling","volume":"74","author":"Meadows","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2021.12.006_bb0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1152\/physrev.00049.2019","article-title":"Molecular physiology of bile acid signaling in health, disease, and aging","volume":"101","author":"Perino","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.molmed.2021.12.006_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/164_2019_230","article-title":"Bile acid-activated receptors: GPBAR1 (TGR5) and other G protein-coupled receptors","volume":"256","author":"Keitel","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0085","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.12.006_bb0090","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41385-019-0162-4","article-title":"Emerging roles of bile acids in mucosal immunity and inflammation","volume":"12","author":"Chen","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.24681","article-title":"Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes","volume":"55","author":"Studer","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2021.12.006_bb0100","doi-asserted-by":"crossref","first-page":"eaar5551","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate: lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.12.006_bb0105","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.27592","article-title":"Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression","volume":"61","author":"Nagahashi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2021.12.006_bb0110","doi-asserted-by":"crossref","first-page":"30988","DOI":"10.1074\/jbc.M115.668277","article-title":"Taurocholate induces cyclooxygenase-2 expression via the sphingosine 1-phosphate receptor 2 in a human cholangiocarcinoma cell line","volume":"290","author":"Liu","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.12.006_bb0115","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.29076","article-title":"The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2021.12.006_bb0120","doi-asserted-by":"crossref","first-page":"13423","DOI":"10.1038\/srep13423","article-title":"Sphingosine 1-phosphate receptor 2 and 3 mediate bone marrow-derived monocyte\/macrophage motility in cholestatic liver injury in mice","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2021.12.006_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104243","article-title":"Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)\/S1P receptors during chronic liver injury","volume":"359","author":"Zhao","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00109-020-02032-4","article-title":"NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate\/S1P receptor 2\/G\u03b1((12\/13))\/MAPK signaling pathway","volume":"99","author":"Hou","year":"2021","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.molmed.2021.12.006_bb0135","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.molmed.2017.02.002","article-title":"Sphingosine-1-phosphate signaling in inflammatory bowel disease","volume":"23","author":"Nielsen","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2021.12.006_bb0140","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2741\/4505","article-title":"Sphingosine-1 phosphate promotes intestinal epithelial cell proliferation via S1PR2","volume":"22","author":"Chen","year":"2017","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.molmed.2021.12.006_bb0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13046-020-01740-6","article-title":"Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer","volume":"39","author":"Petti","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2021.12.006_bb0150","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1159\/000491985","article-title":"The sphingosine-1-phosphate\/sphingosine-1-phosphate receptor 2 axis in intestinal epithelial cells regulates intestinal barrier function during intestinal epithelial cells-CD4+T-cell interactions","volume":"48","author":"Chen","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.molmed.2021.12.006_bb0155","doi-asserted-by":"crossref","first-page":"2481418","DOI":"10.1155\/2018\/2481418","article-title":"Deoxycholic acid-mediated sphingosine-1-phosphate receptor 2 signaling exacerbates DSS-induced colitis through promoting cathepsin B release","volume":"2018","author":"Zhao","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.molmed.2021.12.006_bb0160","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","article-title":"Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network","volume":"126","author":"Bookout","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.12.006_bb0165","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2021.12.006_bb0170","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1210\/mend.16.5.0828","article-title":"Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors","volume":"16","author":"Moore","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41586-021-03421-6","article-title":"CAR directs T cell adaptation to bile acids in the small intestine","volume":"593","author":"Chen","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.12.006_bb0180","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1172\/JCI26283","article-title":"Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation","volume":"116","author":"Zhou","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2021.12.006_bb0185","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1124\/dmd.114.062307","article-title":"Pregnane X receptor modulates the inflammatory response in primary cultures of hepatocytes","volume":"43","author":"Sun","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.molmed.2021.12.006_bb0190","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3390\/cells9102296","article-title":"PXR functionally interacts with NF-\u03baB and AP-1 to downregulate the inflammation-induced expression of chemokine CXCL2 in mice","volume":"9","author":"Okamura","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.molmed.2021.12.006_bb0195","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.toxlet.2017.02.018","article-title":"Pregnenolone 16\u03b1-carbonitrile ameliorates concanavalin A-induced liver injury in mice independent of the nuclear receptor PXR activation","volume":"271","author":"Kodama","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.molmed.2021.12.006_bb0200","doi-asserted-by":"crossref","first-page":"G1114","DOI":"10.1152\/ajpgi.00528.2006","article-title":"Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression","volume":"292","author":"Shah","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0205","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejphar.2011.06.058","article-title":"Inhibition of NF-\u03baB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells","volume":"668","author":"Mencarelli","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0210","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/pr.2018.14","article-title":"Targeting the PXR-TLR4 signaling pathway to reduce intestinal inflammation in an experimental model of necrotizing enterocolitis","volume":"83","author":"Huang","year":"2018","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.molmed.2021.12.006_bb0215","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s41598-020-58644-w","article-title":"Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's disease","volume":"10","author":"Wilson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2021.12.006_bb0220","doi-asserted-by":"crossref","first-page":"45062","DOI":"10.1074\/jbc.M307145200","article-title":"Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity","volume":"278","author":"Guo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.12.006_bb0225","doi-asserted-by":"crossref","first-page":"49517","DOI":"10.1074\/jbc.M409041200","article-title":"The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity","volume":"279","author":"Zhang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.12.006_bb0230","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.3748\/wjg.v23.i42.7519","article-title":"Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasis","volume":"23","author":"Gabbia","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0235","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.immuni.2020.01.019","article-title":"The xenobiotic transporter Mdr1 enforces T cell homeostasis in the presence of intestinal bile acids","volume":"52","author":"Cao","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2021.12.006_bb0240","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1152\/physrev.00014.2015","article-title":"Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects","volume":"96","author":"Christakos","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.molmed.2021.12.006_bb0245","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.tem.2019.04.005","article-title":"Aligning the paradoxical role of vitamin D in gastrointestinal immunity","volume":"30","author":"Cantorna","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2021.12.006_bb0250","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1070477","article-title":"Vitamin D receptor as an intestinal bile acid sensor","volume":"296","author":"Makishima","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.12.006_bb0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1194\/jlr.M400294-JLR200","article-title":"Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative","volume":"46","author":"Adachi","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2021.12.006_bb0260","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1194\/jlr.M700293-JLR200","article-title":"Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia","volume":"49","author":"Ishizawa","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2021.12.006_bb0265","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1053\/j.gastro.2013.12.027","article-title":"Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol","volume":"146","author":"Chow","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2021.12.006_bb0270","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.30937","article-title":"Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice","volume":"71","author":"Dong","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2021.12.006_bb0275","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3390\/ijms19071975","article-title":"Lithocholic acid is a vitamin D receptor ligand that acts preferentially in the ileum","volume":"19","author":"Ishizawa","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2021.12.006_bb0280","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1194\/jlr.M044420","article-title":"Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice","volume":"55","author":"Cheng","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2021.12.006_bb0285","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.bbagen.2012.09.020","article-title":"Implication of intestinal VDR deficiency in inflammatory bowel disease","volume":"1830","author":"Kim","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2021.12.006_bb0290","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/abbi.1999.1605","article-title":"Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system","volume":"374","author":"Veldman","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.molmed.2021.12.006_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176715","article-title":"Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the vitamin D receptor","volume":"12","author":"Pols","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2021.12.006_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.crohns.2013.01.012","article-title":"Active Crohn's disease is associated with low vitamin D levels","volume":"7","author":"J\u00f8rgensen","year":"2013","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.molmed.2021.12.006_bb0305","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cgh.2016.05.035","article-title":"Low serum vitamin D during remission increases risk of clinical relapse in patients with ulcerative colitis","volume":"15","author":"Gubatan","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0310","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0315","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.12.006_bb0320","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.ajpath.2020.07.010","article-title":"Retinoid-related orphan receptor ROR\u03b3t in CD4(+) T-cell-mediated intestinal homeostasis and inflammation","volume":"190","author":"Mickael","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0325","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.aaa9420","article-title":"Mucosal immunology. Individual intestinal symbionts induce a distinct population of ROR\u03b3+ regulatory T cells","volume":"349","author":"Sefik","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.12.006_bb0330","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-pharmtox-010919-023711","article-title":"(Inverse) agonists of retinoic acid-related orphan receptor \u03b3: regulation of immune responses, inflammation, and autoimmune disease","volume":"60","author":"Jetten","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0335","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.12.006_bb0340","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut ROR\u03b3(+) regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.12.006_bb0345","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","article-title":"Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells","volume":"581","author":"Campbell","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.12.006_bb0350","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/19490976.2020.1732268","article-title":"The microbiome modulating activity of bile acids","volume":"11","author":"Tian","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.molmed.2021.12.006_bb0355","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41586-020-2047-9","article-title":"Global chemical effects of the microbiome include new bile-acid conjugations","volume":"579","author":"Quinn","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.12.006_bb0360","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40168-021-01101-1","article-title":"Review: microbial transformations of human bile acids","volume":"9","author":"Guzior","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.molmed.2021.12.006_bb0365","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1080\/19490976.2020.1748261","article-title":"Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health","volume":"11","author":"Jia","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.molmed.2021.12.006_bb0370","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.37182","article-title":"A selective gut bacterial bile salt hydrolase alters host metabolism","volume":"7","author":"Yao","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.molmed.2021.12.006_bb0375","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0039-128X(80)90115-4","article-title":"Bile acid induction specificity of 7 alpha-dehydroxylase activity in an intestinal Eubacterium species","volume":"35","author":"White","year":"1980","journal-title":"Steroids"},{"key":"10.1016\/j.molmed.2021.12.006_bb0380","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.12.006_bb0385","doi-asserted-by":"crossref","first-page":"eaav1282","DOI":"10.1126\/science.aav1282","article-title":"Depletion of microbiome-derived molecules in the host using Clostridium genetics","volume":"366","author":"Guo","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.12.006_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1854008","article-title":"The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice","volume":"13","author":"Streidl","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.molmed.2021.12.006_bb0395","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0400","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2021.12.006_bb0405","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3748\/wjg.v27.i24.3609","article-title":"Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis","volume":"27","author":"Yang","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0410","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","article-title":"Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases","volume":"62","author":"Duboc","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2021.12.006_bb0415","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","article-title":"Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation","volume":"27","author":"Sinha","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molmed.2021.12.006_bb0420","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/gutjnl-2016-311915","article-title":"The gut-adherent microbiota of PSC-IBD is distinct to that of IBD","volume":"66","author":"Quraishi","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2021.12.006_bb0425","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2021.12.006_bb0430","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/2050640617708953","article-title":"The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease","volume":"6","author":"Torres","year":"2018","journal-title":"United European Gastroenterol J."},{"key":"10.1016\/j.molmed.2021.12.006_bb0435","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CEG.S186097","article-title":"A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis","volume":"12","author":"Vaughn","year":"2019","journal-title":"Clin. Exp. Gastroenterol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0440","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ecco-jcc\/jjaa021","article-title":"A pilot integrative analysis of colonic gene expression, gut microbiota, and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways","volume":"14","author":"Quraishi","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.molmed.2021.12.006_bb0445","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/hep.31228","article-title":"Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability in mice","volume":"72","author":"Isaacs-Ten","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2021.12.006_bb0450","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s42255-021-00452-1","article-title":"Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling","volume":"3","author":"Schneider","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.molmed.2021.12.006_bb0455","doi-asserted-by":"crossref","first-page":"18024","DOI":"10.1074\/jbc.271.30.18024","article-title":"Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase","volume":"271","author":"Schwarz","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.12.006_bb0460","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1194\/jlr.M071183","article-title":"Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans","volume":"57","author":"Takahashi","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2021.12.006_bb0465","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3727\/105221619X15614873062730","article-title":"Inflammation and cell death during cholestasis: the evolving role of bile acids","volume":"19","author":"Woolbright","year":"2019","journal-title":"Gene Expr."},{"key":"10.1016\/j.molmed.2021.12.006_bb0470","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2020.09.035","article-title":"Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis","volume":"74","author":"Cai","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0475","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jcsm.12652","article-title":"Inflammation-induced cholestasis in cancer cachexia","volume":"12","author":"Thibaut","year":"2021","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.molmed.2021.12.006_bb0480","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2021.12.006_bb0485","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","article-title":"An overview of the immune system","volume":"357","author":"Parkin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2021.12.006_bb0490","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/ijms19030730","article-title":"The balance of Th17 versus Treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2021.12.006_bb0495","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/abbi.1999.1295","article-title":"Small and large unilamellar vesicle membranes as model system for bile acid diffusion in hepatocytes","volume":"368","author":"Hofmann","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.molmed.2021.12.006_bb0500","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41575-019-0173-3","article-title":"Probiotics and prebiotics in intestinal health and disease: from biology to the clinic","volume":"16","author":"Sanders","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0505","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/gutjnl-2016-313316","article-title":"Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction","volume":"67","author":"Catry","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2021.12.006_bb0510","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.1323599111","article-title":"Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut","volume":"111","author":"Joyce","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2021.12.006_bb0515","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1136\/gutjnl-2018-317842","article-title":"Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection","volume":"68","author":"Mullish","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2021.12.006_bb0520","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41575-019-0163-5","article-title":"Language, numeracy and logic in microbiome science","volume":"16","author":"Shanahan","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2021.12.006_bb0525","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40168-020-00875-0","article-title":"Microbiome definition re-visited: old concepts and new challenges","volume":"8","author":"Berg","year":"2020","journal-title":"Microbiome"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491421003233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491421003233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:24:24Z","timestamp":1761463464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491421003233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":105,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1471491421003233"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2021.12.006","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2021.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}